Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-002610
Filing Date
2023-03-01
Accepted
2023-03-01 17:21:09
Documents
80
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tgtx-20221231x10k.htm   iXBRL 10-K 2412306
2 EX-21.1 tgtx-20221231xex21d1.htm EX-21.1 4390
3 EX-23.1 tgtx-20221231xex23d1.htm EX-23.1 2086
4 EX-23.2 tgtx-20221231xex23d2.htm EX-23.2 2203
5 EX-31.1 tgtx-20221231xex31d1.htm EX-31.1 13519
6 EX-31.2 tgtx-20221231xex31d2.htm EX-31.2 13480
7 EX-32.1 tgtx-20221231xex32d1.htm EX-32.1 6649
8 EX-32.2 tgtx-20221231xex32d2.htm EX-32.2 6587
9 GRAPHIC tgtx-20221231x10k001.jpg GRAPHIC 74667
  Complete submission text file 0001558370-23-002610.txt   8862110

Data Files

Seq Description Document Type Size
10 EX-101.SCH tgtx-20221231.xsd EX-101.SCH 58664
11 EX-101.CAL tgtx-20221231_cal.xml EX-101.CAL 66422
12 EX-101.DEF tgtx-20221231_def.xml EX-101.DEF 190110
13 EX-101.LAB tgtx-20221231_lab.xml EX-101.LAB 483002
14 EX-101.PRE tgtx-20221231_pre.xml EX-101.PRE 351485
74 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20221231x10k_htm.xml XML 1477045
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 23695062
SIC: 2834 Pharmaceutical Preparations